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Abstract
Assessment of the potential risk of in flight hypoxaemia in patients with cystic fibrosis is often based on a hypoxic challenge
where individuals have saturations andyor blood gases taken before and after inspiring 15% normobaric oxygen. The aim of this
study was to see if routine clinical measurements could predict the outcome of this test. This was a prospective study comparing
the modified 6-min walking test, lung function, body mass index, Northern (N) and Shwachman–Kulczycki (SK) scores with a
hypoxic challenge (flight test) in 69 adults attending the Leeds regional CF Unit. Although, there was a significant correlation
between post flight test PaO and N score (Ps0.003), SK score (Ps0.002), FVC % predicted (Ps0.01), FEV % predicted2 1
(Ps0.002), resting saturations (P-0.001), 6 min saturation on walking test (P-0.001) and baseline PaO (P-0.001), no single2
parameter could accurately predict all patients who desaturated during the flight test. No individual clinical parameter appears to
fully predict the need for in flight oxygen but patients most at risk appear to have either a low FEV (-60%), high N score ()1
13) or low baseline PaO (-10.5 kPa).2
 2002 European Cystic Fibrosis Society. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Patients with cystic fibrosis appear to tolerate in flight
hypoxaemia extremely well w1x. However there have
been reports of severe respiratory decompensation occur-
ring following high altitude hypoxaemia w2x. Patients
with advanced lung disease and baseline hypoxaemia
will be identified clinically. The difficulty lies in iden-
tifying those individuals who do not fit into this sub-
group but nevertheless are at risk of in flight
desaturation.
An evaluation of in flight hypoxaemia can be carried
out using the fitness to fly test where individuals have
saturations and blood gases taken before and after
inspiring 15% normobaric oxygen for a period of 15
min w3,4x. The test is time consuming and disliked by
some patients.
The aim of this study was to see if routine clinical
measurements of lung function, annual Northern (N) w5x
and Shwachman–Kulczycki (SK) w6x scores, body mass
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index (BMI) and a modified 6-min walking test could
predict the outcome of a hypoxic challenge and thereby
reduce the requirement for this test.
2. Method
2.1. Study design
This was a prospective study comparing, the modified
6-min walking test, lung function, BMI, N score and
SK clinical score with the hypoxic challenge (flight
test) in adult patients attending the Leeds regional CF
Unit. All patients were clinically stable at the time of
investigation.
2.2. Subjects
Sixty-nine subjects were studied between March 1999
and November 2001. All patients had characteristic
radiological and clinical features of cystic fibrosis and
had been diagnosed on two positive sweat test andyor
two CF mutations.
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2.3. Lung function
Forced expiratory volume in 1 s (FEV ) and forced1
vital capacity (FVC) were measured as the highest of
three blows on a Vitalograph (Compact II) within 4
weeks of the flight test and when subjects were clinically
stable.
2.4. The fitness to fly test
A fitness to fly test using the hypoxic inhalation test
was carried out within 8 weeks of the travel date. A
100-l Douglas bag was flushed and then filled with 15%
O , 85% N from a certified BOC cylinder. The Douglas2 2
bag was fitted with a three-way tap and attached to a
two-way valve box and mouthpiece. Nose clips were
worn during the procedure and the valve box ensured
that the patient inspired from the bag and expired into
the room. Resting PaO was then measured by perform-2
ing capillary blood gases. Each patient was then con-
nected to an oximeter and allowed to breathe from the
Douglas bag circuit for a 15-min period. Oximeter
readings were used to give an indication of when the
patient had stabilised. A second capillary blood gas was
then taken to establish the fall in PaO at the end of the2
test. In patients where blood gas measurements were
unavailable a saturation below 85% was regarded as a
positive test.
2.5. Radiology and clinical scores
The radiological and clinical scores were determined
by using the Northern w5x method and the SK w6x
clinical score, respectively.
2.6. Criteria for oxygen therapy
A fall in PaO to 6.7 kPa or below was taken as a2
positive test and is the minimum desirable level of
PaO during a flight. If saturations fell to -85% the2
procedure was stopped and blood gas measured. During
the study, patients with a PaO of less than 7 kPa were2
prescribed in flight oxygen. Patients with a PaO approx-2
imately 7 kPa were advised to have oxygen available
during their flight, especially if there had been evidence
of significant hyperventilation during the assessment or
if they were planning a long haul flight.
2.7. The 6-min walking test
A modified 6-min walking tests was carried out within
6 months of the flight test. Patients walked on the flat
for 6 min on a treadmill whilst monitoring SaO and2
heart rate at a speed determined by the patient.
2.8. Data analysis
Because the data were not normally distributed they
were expressed as medians and ranges. In patients who
had undergone two flight tests, changes in exercise
induced desaturation, lung function, BMI, N score, SK
score and hypoxic challenge PaO levels were analysed2
using the Wilcoxon matched pairs test. The degree of
correlation between the various measured parameters
and flight test desaturation was analysed by calculating
the Pearson Rank correlation coefficient (Microsoft
Corporation, Redmond, USA). A P value of -0.05 was
regarded as significant.
3. Results
Sixty-nine subjects with a median (range) age of 23
(16–41) years were studied. Median (range) BMI, SK
and N scores were 20.5 (15.2–27.7), 70 (40–95) and
14 (2–18). Median (range) FEV , FEF and FVC1 25–75
predicted were 47% (17–98), 20% (4–108) and 69%
(17–106), respectively. Follow up studies were under-
taken in 13 subjects. There were incomplete serial blood
gas measurements in 7 patients due to either inadequate
or clotted samples or transient equipment malfunction.
One subject was unable to tolerate capillary blood gas
measurements. Two patients failed to attend for their
exercise test.
There was a significant correlation between post flight
test PaO and N score (Ps0.003), SK score (Ps2
0.002), FVC % predicted (Ps0.01), FEV % predicted1
(Ps0.002), FEF % predicted (Ps0.002), resting25–75
saturations (P-0.001), 6 min saturation on walking test
(P-0.001), lowest exercise desaturation (Ps0.049)
and baseline PaO (P-0.001). There was no significant2
correlation between either age, BMI or 6 min walking
distance and post flight PaO . Similar results were seen2
when comparing lowest flight assessment desaturations
with all the above parameters.
Median (range) lowest desaturation during 6-min
walking test was 92% (79–97). Median (range) pre-
flight assessment PaO , post flight assessment PaO and2 2
lowest flight assessment saturations were 10.5 (8.2–
14.6) kPa, 7.9 (6.2–13.4) kPa and 90.5% (83–97),
respectively.
3.1. Positive flight test
A positive flight test, where the PaO fell to 6.7 kPa2
or below, occurred in 7y69 patients (Table 1). In a
further patient post flight assessment PaO was unavail-2
able but saturations fell below 84% shortly after starting
and the test was regarded as positive.
Six subjects had a post flight PaO of greater then2
6.7 kPa but less than 7 kPa (Table 1). Overall, a PaO2
of -7 kPa at the end of a flight assessment was
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Table 1
Median (range) for the various clinical parameters measured according to the level of the PaO taken at the end of a formal pre-flight hypoxic2
challenge
Positive flight test 6.7(PaO -72 7(PaO -82 PaO )82
kPa kPa kPa
Number of subjects 8 6 18 30
Age (years) 30 (25–35) 30 (17–37) 21 (18–29) 22 (16–41)
BMI 20.15 (16–22.5) 19.6 (15.2–27.2) 20.1 (17.2–26.6) 21.1 (17.5–26.5)
Shwachman 61 (40–75) 59 (40–90) 70 (55–90) 80 (45–95)
Northern 15 (13–18) 15 (10–16) 14 (9–16) 12 (2–17)
FVC (% predicted) 55.5 (17–75) 70.5 (40–106) 68 (40–87) 71.5 (37–106)
FEV (% predicted)1 31.5 (17–52) 36.5 (30–81) 44 (28–84) 51 (25–98)
FEF (% predicted)25–75 12 (4–21) 18 (6–40) 16 (9–71) 29 (7–108)
Baseline saturation 93 (90–99) 95.5 (94–97) 96 (93–99) 97 (91–99)
6 min saturation (%) 92 (79–99) 93 (91–98) 94 (83–98) 96 (90–99)
Lowest saturation on exercise (%) 89 (79–94) 90 (89–92) 92 (84–97) 93 (85–97)
Distance (m) 447 (400–500) 504 (350–654) 452 (240–686) 497 (420–641)
Baseline PaO (kPa)2 8.65 (8.2–10.4) 9.6 (92–10.1) 9.9 (9–12) 11.3 (8.3–14.6)
Post flight assessment PaO (kPa)2 6.5 (6.2–6.7) 6.9 (6.8–6.9) 7.6 (7.2–7.9) 8.85 (8–13.4)
Lowest saturations (%) 85 (83–87) 86.5 (85–88) 89 (84–94) 92 (87–96)
In 1 patient post flight assessment PaO was unavailable but saturations fell below 84% shortly after starting and the test was regarded as2
positive.
associated with a higher median age, worse lung func-
tion and worse clinical and radiological scores. The
highest % predicted FEV was 52% in those with a1
positive flight test (Fig. 1).
Median (range) BMI, SK score, N score, % predicted
FEV , FEF and FVC and lowest desaturation during1 25–75
6-min walking test, pre-flight assessment PaO , and2
lowest flight assessment saturations according to the
level of post flight assessment PaO are summarised in2
Table 1. Comparisons between baseline PaO and level2
of hypoxaemia following in flight assessment is shown
in Fig. 2.
Sequential blood gas analysis showed a median
(range) change in pH and CO of y0.013 (y0.21 to2
0.1) and y0.12 kPa (y2.93 to 1.44), respectively.
Twenty-seven (43%) patients showed an element of
hyperventilation according to sequential blood gases.
The prevalence of hyperventilation was 40% in subjects
who had desaturated below 8 kPa. There was no corre-
lation between the degree of hyperventilation and out-
come of the flight test.
No patients recorded an adverse response during their
flight although patients with a positive flight test or
significant hypoxaemia had received in flight oxygen on
a continuous or as required basis. One patient developed
a small pneumothorax and mild exacerbation on return-
ing from their holiday requiring hospital treatment.
3.2. Repeat studies
Thirteen subjects underwent a second flight assess-
ment. The median (range) of time between assessments
was 16 (9–25) months (Table 2). Two patients who
had previously had a positive flight test showed similarly
low PaO . There was an overall trend to improvements2
in both post flight test PaO and desaturation levels on2
the second test.
4. Discussion
Aircraft fly at altitudes of between 9150 and 12 200
m. The cabin must therefore be pressurised with cabin
altitude approaching approximately 2460 m and with
inspired oxygen concentration being approximately 15%
w4x. In normal circumstances this results in a small and
insignificant fall in oxygen blood saturation. However,
the presence of chronic lung disease may give rise to
significant in flight hypoxaemia as a result of the shape
of the oxygen dissociation curve and the presence of
ventilationyperfusion mismatch w4,7x.
While the clinical importance of transient high altitude
flight hypoxaemia is unclear and individual tolerance
variable, high altitude induced hypoxaemia has been
reported in a small number of cases to cause significant
clinical deterioration w2,4x.
The fitness to fly test where individuals have satura-
tions andyor blood gases taken before and after inspiring
15% normobaric oxygen for a period of 15 min remains
the gold standard in many centres with the minimum
desired PaO for flight being an arbitrary value of 6.72
kPa w4,7x. A recent study Buchdahl et al. challenges this
concept w8x. They compared pre-flight hypoxic challenge
and in flight saturations in a large population of 87
children with cystic fibrosis. They concluded that pre-
flight spirometry testing was a better predictor of desa-
turation during flight than the pre-flight hypoxic
challenge. Importantly those children with more severe
disease who were likely to benefit from in flight oxygen
(SaO of -86%) were advised not to fly. The presence2
of moderate desaturation itself is not an indication for
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Fig. 1. This figure demonstrates the distribution of FEV according to the various subgroups of the PaO taken at the end of a formal pre-flight1 2
hypoxic challenge.
Fig. 2. Comparison between baseline PaO and level of hypoxia following in flight assessment.2
Table 2
Comparisons between pre-flight hypoxic challenges in 13 patients who had undergone two tests during the study period
First flight Follow up flight P value
Time (month) 16 (9–25)
SK score (ns13) 62 (45–90) 65 (40–85) )0.05
N score (ns13) 15 (7–17) 15 (10–19) )0.05
FVC (ns13) (% predicted) 69 (51–90) 65 (31–82) 0.02
FEV (ns13) (% predicted)1 42 (25–76) 42 (19–66) 0.2
PaO (ns10) (kPa)2 7.4 (6.5–8.7) 10.05 (6.7–12.6) )0.05
Lowest saturation % 89 (84–92) 88 (87–93) 0.001
Hyperventilation (n) 3y10 4y10
oxygen therapy. During flight, a single measurement of
PaO was made at cruising altitude and when children2
fell asleep. The discrepancy between the predictive value
of pre-flight SaO and in flight desaturation may have2
occurred for several reasons. Firstly, hyperventilation is
common during flight assessment occurring in up to
43% of our patients. This will cause a shift of the
oxygen dissociation curve to the left and result in an
over estimation of predicted flight saturations. Secondly,
a cut off value of 90% SaO was the value used in their2
study and this may have resulted in some patients with
true desaturation according to arterial blood gases being
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Table 3
Number of patients with a lowest SaO falling to or below 90% according to the level of PaO taken at the end of a formal pre-flight hypoxic2 2
challenge
Positive flight 6.7(PaO -72 7(PaO -82 PaO )82
test kPa kPa kPa
Total number of patients in each group 7 6 18 29
Fall in saturation to -90% during flight test 7 (100%) 6 (100%) 12 (66%) 6 (21%)
Fig. 3. This figure demonstrates the distribution of the N score according to the various subgroups of the PaO (kPa) taken at the end of a formal2
pre-flight hypoxic challenge.
missed (Table 3). Using this cut off point in our study
for SaO , 44% of patients with an end PaO greater2 2
than 7 kPa but less than 8 kPa would have been excluded
from analysis, while 21% of patients with an end PaO2
of )8 kPa would have been included. Finally, mild
exacerbations could have significantly impacted on the
predictive value of the pre-flight hypoxic challenge.
In a previous study by the same group they compared
finger probe oximetry in air and in 15% oxygen and
then compared these results to oximetry during high
altitude and on a mountain altitude of 18 000 feet w3x.
In this study they found that the hypoxic challenge
directly predicted the worse case of desaturation during
flight and at equivalent altitude while spirometry under-
estimated individual hypoxic response. Again only mod-
erate desaturations were observed in this group of
patients. Clearly further studies are needed to clarify the
predictive value of the pre-flight hypoxic challenge with
respect to in flight desaturation, especially among adults.
We found that no single clinical parameter predicted
accurately and specifically those patients at risk of
desaturation during hypoxic challenge. There was a clear
correlation between disease severity and flight assess-
ment induced hypoxaemia, although neither SK score,
N score (Fig. 3), lung function (Fig. 1), post exercise
desaturation, resting saturations or baseline PaO (Fig.2
2) could predict all those at risk. The most sensitive
measure appears to be % predicted FEV , the highest1
level being 52% in one patients with positive hypoxaem-
ic challenge (PaO 6.7 kPa or below) (Fig. 1). However,2
a significant number of patients with an FEV of less1
than 52% predicted had a negative flight test while 2
patients who had a PaO -7 kPa at the end of their2
assessment had significantly higher respiratory function.
A study by Ross et al. looking at the hypoxic inhalation
test in 27 adults with cystic fibrosis describe similar
results where resting SaO and FEV could not accu-2 1
rately predict hypoxaemia during in flight simulation
w9x.
The incidence of desaturation during flight assessment
appears to be significantly higher in adult patients than
in children as might be expected. In this study, 52% of
patients had an end PaO -8.0 kPa and 22.6% had a2
PaO -7 kPa following the procedure.2
Although there is a generally accepted cut off point
for prescribing oxygen, the value is arbitrary and
excludes patients at risk of significant desaturation.
During the study period, only 1 patient deteriorated and
required hospital admission after flying. The individual
had flown without oxygen and against medical advise.
The adverse events reported in the study by Buchdahl
et al. reached 50% with 5y10 children who desaturated
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during their flight feeling breathlessness w8x. Some
symptoms may have resulted from the study being
unblinded. This differs from a study by Rose et al. who
performed hyperbaric chamber flight assessments in 10
children, reaching pressures of 3000 m w1x. Significantly
greater hypoxaemia occurred with only 1 patient having
a PaO )50 mmHg. Despite this significant desaturation2
there were no adverse symptoms apart from two cases
of mild ear barotraumas.
In this study, a small number of patients under went
two flight assessments. Although there was little change
in clinical status and lung function there was an overall
trend to improvement in post flight assessment PaO .2
This may well have resulted by increased awareness by
both doctors and patients to previous flight tests and a
tendency to institute prompt treatment prior to holidays.
While the clinical importance of transient high altitude
flight hypoxaemia is far from clear, individual tolerance
is likely to be variable. Altitude induced hypoxaemia
can induce significant clinical deterioration and it is
common sense to take practical measures to avoid this
w2x. Desaturation during hypoxic challenge is common
in adult patients with cystic fibrosis. While no specific
clinical parameter appears to predict the need for in
flight oxygen, those most at risk appear to have either
a low FEV (-60%), high N score ()13), low baseline1
PaO (-10.5). Desaturation during the 6-min walking2
test alone does not appear to be a good predictor of a
positive flight test.
Further clinical studies are needed to determine the
clinical impact of in flight desaturation and the precise
role of pre-flight hypoxic testing as the evidence to date
is limited both in patients with cystic fibrosis and other
chronic respiratory diseases.
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